Prostaglandin analogue misoprostol attenuates neurotoxin 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells

Brain Research Bulletin

Volumn 77, Issue 5, 2008, Pages 293-300

  Choi, Eun Joo ^a   Han, Jeong Ho ^b   Lee, Chung Soo ^a  

^a Chung Ang University   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

Author keywords

1 Methyl 4 phenylpyridinium; Cell death; Misoprostol; Mitochondrial membrane permeability change; PC12 cells; Protection

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CASPASE 3; CYTOCHROME C; GLUTATHIONE; MISOPROSTOL; NEUROTOXIN; PROSTAGLANDIN E1; PROTEIN BAX; ROTENONE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ALPROSTADIL; ANIMALS; ANTI-ULCER AGENTS; CELL DEATH; CELL NUCLEUS; FREE RADICAL SCAVENGERS; GLUTATHIONE; HERBICIDES; MISOPROSTOL; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PC12 CELLS; PERMEABILITY; RATS; REACTIVE OXYGEN SPECIES; ROTENONE; UNCOUPLING AGENTS;

EID: 54549091151     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.06.006     Document Type: Article

References (46)

1. Berthier A., Lemaire-Ewing S., Prunet C., Monier S., Athias A., Bessede G., Pais de Barros J.P., Laubriet A., Gambert P., Lizard G., and Neel D. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 11 (2004) 897-905
2. Bonuccelli U., and Del Dotto P. New pharmacological horizons in the treatment of Parkinson disease. Neurology 67 (Suppl. 2) 7 (2006) S30-S38
3. Bové J., Prou D., Perier C., and Przedborski S. Toxin-induced models of Parkinson's disease. The Journal of the American Society for Experimental NeuroTherapeutics 2 (2005) 484-494
4. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453 (1999) 49-62
5. Choi H.J., Lee S.Y., Cho Y., No H., Kim S.W., and Hwang O. Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: implications for Parkinson's disease. Neurochem. Int. 48 (2006) 255-262
6. +. Brain Res. Mol. Brain Res. 119 (2003) 50-61
7. Constantini P.C., Chernyak B.C., Petronilli V., and Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271 (1996) 6746-6751
8. Crow M.T., Mani K., Nam Y.-J., and Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 95 (2004) 957-970
9. De Vries N., and De Flora S. N-Acetyl-l-cysteine. J. Cell. Biochem. Suppl. 17F (1993) 270-277
10. Echeverria V., Clerman A., and Dore S. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. Eur. J. Neurosci. 22 (2005) 2199-2206
11. Fu W., Luo H., Parthasarathy S., and Mattson M.P. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis. 5 (1998) 229-243
12. Hall A.G. The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 29 (1999) 238-245
13. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S26-S38
14. Kadota T., Yamaai T., Saito Y., Akita Y., Kawashima S., Moroi K., Inagaki N., and Kadota K. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J. Histochem. Cytochem. 44 (1996) 989-996
15. 1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. Neuropharmacology 36 (1997) 1023-1030
16. Kim R., Emi M., and Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother. Pharmacol. 57 (2006) 545-553
17. Kim Y.J., Ko H.H., Han E.S., and Lee C.S. Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death. Brain Res. Bull. 79 (2007) 633-640
18. +-induced mitochondrial damage and cell death by trifluoperazine and W-7 in PC12 cells. Neurochem. Int. 46 (2005) 169-178
19. Lee C.S., Park W.J., Ko H.H., and Han E.S. Differential involvement of mitochondrial permeability transition in cytotoxicity of 1-methyl-4-phenylpyridinium and 6-hydroxydopamine. Mol. Cell. Biochem. 289 (2006) 193-200
20. 2α exacerbate hypoxic neuronal injury in neuron-enriched primary culture. Neurochem. Res. 33 (2008) 490-499
21. Lindenboim L., Yuan J., and Stein R. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells. Oncogene 19 (2000) 1783-1793
22. Lipman T., Tabakman R., and Lazarovici P. Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the Nerve Growth Factor-differentiated model of pheochromocytoma PC12 cells. Eur. J. Pharmacol. 549 (2006) 50-57
23. Martínez M., Martínez N., Hernández A.I., and Ferrándiz M.L. Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease?. Life Sci. 64 (1999) 1253-1257
24. 2 EP2 receptor in cerebral ischemia. J. Neurosci. 24 (2004) 257-268
25. Mignotte B., and Vayssière J.L. Mitochondria and apoptosis. Eur. J. Biochem. 252 (1998) 1-15
26. Misiti F., Orsini F., Clementi M.E., Lattanzi W., Giardina B., and Michetti F. Mitochondrial oxygen consumption inhibition importance for TMT-dependent cell death in undifferentiated PC12 cells. Neurochem. Int. 52 (2008) 1092-1099
27. Moraes B.M., do Amaral B.C., Morimoto M.S., Vieira L.G., Perazzo F.F., and Carvalho J.C. Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol. Inflammopharmacology 15 (2007) 175-178
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
29. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
30. Norenberg M.D., and Rama Rao K.V. The mitochondrial permeability transition in neurologic disease. Neurochem. Int. 50 (2007) 983-997
31. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., and Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 5408-5412
32. 1 induces c-Fos and Myc proteins and protects rat hippocampal cells against hypoxic injury. J. Cereb. Blood Flow Metab. 14 (1994) 150-155
33. Ott M., Gogvadze V., Orrenius S., and Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 12 (2007) 913-922
34. 1 protection against apoptosis induced by d-galactosamine is not related to the modulation of intracellular free radical production in primary culture of rat hepatocytes. Free Radic. Res. 36 (2002) 345-355
35. Radad K., Rausch W.D., and Gille G. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem. Int. 49 (2006) 379-386
36. Rong P., Bennie A.M., Epa W.R., and Barrett G.L. Nerve growth factor determines survival and death of PC12 cells by regulation of the bcl-x, bax, and caspase-3 genes. J. Neurochem. 72 (1999) 2294-2300
37. Sen T., Sen N., Jana S., Khan F.H., Chatterjee U., and Chakrabarti S. Depolarization and cardiolipin depletion in aged rat brain mitochondria: relationship with oxidative stress and electron transport chain activity. Neurochem. Int. 50 (2007) 719-725
38. 1 abolishes the mitochondrial-independent cell death pathway induced by d-galactosamine in primary culture of rat hepatocytes. J. Gastroenterol. Hepatol. 20 (2005) 108-116
39. Storch A., Ludolph A.C., and Schwarz J. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J. Neural Transm. 111 (2004) 1267-1286
40. 2 deteriorates N-methyl-d-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons. Life Sci. 78 (2006) 1878-1883
41. Tatton W.G., Chalmers-Redman R.M.E., Ju W.J.H., Mammen M., Carlile G.W., Pong A.W., and Tatton N.A. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J. Pharmacol. Exp. Ther. 301 (2002) 753-764
42. 2 analogue, OP-41483. J. Am. Coll. Surg. 187 (1998) 276-286
43. van Klaveren R.J., Hoet P.H.M., Pype J.L., Demedts M., and Nemery B. Increase in γ-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic. Biol. Med. 22 (1997) 525-534
44. Walt R.P. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N. Engl. J. Med. 327 (1992) 1575-1580
45. Wu Y., Shang Y., Sun S.G., Liu R.G., and Yang W.Q. Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells. Neurosci. Bull. 23 (2007) 156-164
46. 1 protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc. Res. 64 (2002) 94-103